Plain-English translation of NCT03178630 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is testing whether advanced MRI imaging—a type of detailed scan that creates pictures of your liver—can better predict how autoimmune liver disease will develop over time in young people. Researchers will take MRI scans at the beginning of the study and again after 1 and 2 years, then track your health for 10 years total. The goal is to see if these scans can spot disease progression earlier and more accurately than standard blood tests alone.
Autoimmune liver diseases, including autoimmune hepatitis and primary sclerosing cholangitis, can seriously damage young people's livers, but doctors don't have a reliable way to predict which patients will get worse. This study exists to find out whether special MRI imaging can help doctors catch complications earlier and make better treatment decisions.
You likely qualify if…
You likely don't qualify if…
You would come to the hospital for MRI scans at the start of the study, then again after 1 year and 2 years. Between and after these visits, your doctors will collect your routine blood work and clinical information from your regular appointments for 10 years. The MRI itself is painless and typically takes 30–60 minutes; you lie still inside the scanner while it takes detailed pictures of your liver. There are no medications to take as part of this study.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
United States